SCHEMBL9708799

SCHEMBL9708799

O=c1[nH]c(=O)n(CC2CC2)c2nc(C3CCCCC3)n(Cc3ccc(-c4ccccc4-c4nnn[nH]4)cc3)c12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.51
AGTR1 P30556 3/20 0.43
AGTR2 P50052 3/20 0.43
MEN1 O00255 6/20 0.40
POLB P06746 2/20 0.40
RAB9A P51151 1/20 0.40
MTOR P42345 2/20 0.38
ALDH1A1 P00352 3/20 0.37
KDM4E B2RXH2 2/20 0.37
LMNA P02545 1/20 0.37
HTT P42858 2/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
NPSR1 Q6W5P4 2/20 0.37
ADORA3 P0DMS8 1/20 0.37
PDE5A O76074 1/20 0.36
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9708284 0.91 KMT2A (0.54) KMT2AAGTR1AGTR2MEN1POLB
SCHEMBL9708443 0.90 KMT2A (0.55) KMT2AAGTR1AGTR2MEN1POLB
SCHEMBL9708457 0.90 KMT2A (0.55) KMT2AAGTR1AGTR2MEN1POLB
SCHEMBL9707885 0.89 KMT2A (0.52) KMT2AAGTR1AGTR2MEN1POLB
SCHEMBL9708565 0.89 KMT2A (0.55) KMT2AAGTR1AGTR2MEN1POLB
SCHEMBL9708373 0.88 PDE5A (0.48) KMT2AAGTR1AGTR2ADORA3PDE5A
SCHEMBL9707780 0.88 KMT2A (0.53) KMT2AAGTR1AGTR2MEN1POLB
SCHEMBL9708489 0.88 AGTR1 (0.41) KMT2AAGTR1AGTR2MEN1MTOR
SCHEMBL9708760 0.88 KMT2A (0.49) KMT2AAGTR1AGTR2MEN1POLB
SCHEMBL9708792 0.87 KMT2A (0.50) KMT2AAGTR1AGTR2MEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992007852-A1 BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed